Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).
Industry description
The investment seeks long-term capital appreciation.
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.
Market Cap
The average market capitalization across the T. Rowe Price Health Sciences I MF is 269.64B. The market cap for tickers in the group ranges from 102.31B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is VRTX at 102.31B.
Volume
The average weekly volume growth across all stocks in the T. Rowe Price Health Sciences I MF was 154%. For the same stocks of the MF, the average monthly volume growth was 159% and the average quarterly volume growth was 75%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 53
P/E Growth Rating: 61
Price Growth Rating: 57
SMR Rating: 59
Profit Risk Rating: 26
Seasonality Score: 3 (-100 ... +100)